Regeneron Pharmaceuticals’ gene therapy, DB-OTO, has shown promising initial results in improving hearing for chil...
Neva Sgr Invests in Bio4Dreams to Boost Innovation in Life Sciences
Turin/Milan, 16 July 2024 – Neva Sgr, the venture capital arm of the Intesa Sanpaolo Group, has taken an equity st...
The Unified Patent Court: a historic turning point in the European patent landscape
The Unified Patent Court(“UPC”) became operational on 1 June 2023: it is a supranational court with exclusiv...
The Future of Weight Loss: What Will Be Next After Wegovy?
The next generation of weight loss treatments promises to be more effective, convenient, and accessible, building on the...
BionIT Labs closes a €5.5 million investment round with CDP Venture Capital Sgr, RIF Srl, Sefea Impact Sgr, SIMEST SpA, and Fondazione ENEA Tech e Biomedical
Investment goal: to make the Adam’s Hand bionic prosthesis the premier product in the American prosthetic market and t...
New Horizons in Type 1 Diabetes: FDA Approval of Lantidra and Emerging Therapies
The FDA has approved Lantidra, a groundbreaking donor-derived pancreatic islet cell therapy for type 1 diabetes, providi...